181 related articles for article (PubMed ID: 37364815)
1. Incidence of Epstein-Barr virus reactivation is elevated in COVID-19 patients.
Bernal KDE; Whitehurst CB
Virus Res; 2023 Sep; 334():199157. PubMed ID: 37364815
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics and outcomes of critically ill patients with acute COVID-19 with Epstein-Barr virus reactivation.
Xie Y; Cao S; Dong H; Lv H; Teng X; Zhang J; Wang T; Zhang X; Qin Y; Chai Y; Yang L; Liu J; Wang R
BMC Infect Dis; 2021 Sep; 21(1):955. PubMed ID: 34525962
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus reactivation is not causative for post-COVID-19-syndrome in individuals with asymptomatic or mild SARS-CoV-2 disease course.
Hoeggerl AD; Nunhofer V; Lauth W; Badstuber N; Held N; Zimmermann G; Grabmer C; Weidner L; Jungbauer C; Lindlbauer N; Neureiter H; Ortner T; Flamm M; Osterbrink J; Rohde E; Laner-Plamberger S
BMC Infect Dis; 2023 Nov; 23(1):800. PubMed ID: 37968601
[TBL] [Abstract][Full Text] [Related]
4. Positive Epstein-Barr virus detection in coronavirus disease 2019 (COVID-19) patients.
Chen T; Song J; Liu H; Zheng H; Chen C
Sci Rep; 2021 May; 11(1):10902. PubMed ID: 34035353
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr Virus and Human Herpesvirus-6 Reactivation in Acute COVID-19 Patients.
Brooks B; Tancredi C; Song Y; Mogus AT; Huang MW; Zhu H; Phan TL; Zhu H; Kadl A; Woodfolk J; Jerome KR; Zeichner SL
Viruses; 2022 Aug; 14(9):. PubMed ID: 36146679
[TBL] [Abstract][Full Text] [Related]
6. [Reactivation of Epstein-Barr virus (
Solomay TV; Semenenko TA; Filatov NN; Vedunova SL; Lavrov VF; Smirnova DI; Gracheva AV; Faizuloev EB
Vopr Virusol; 2021 May; 66(2):152-161. PubMed ID: 33993685
[TBL] [Abstract][Full Text] [Related]
7. Reactivation of EBV and CMV in Severe COVID-19-Epiphenomena or Trigger of Hyperinflammation in Need of Treatment? A Large Case Series of Critically ill Patients.
Naendrup JH; Garcia Borrega J; Eichenauer DA; Shimabukuro-Vornhagen A; Kochanek M; Böll B
J Intensive Care Med; 2022 Sep; 37(9):1152-1158. PubMed ID: 34791940
[TBL] [Abstract][Full Text] [Related]
8. Epstein Barr Virus Reactivation during COVID-19 Hospitalization Significantly Increased Mortality/Death in SARS-CoV-2(+)/EBV(+) than SARS-CoV-2(+)/EBV(-) Patients: A Comparative Meta-Analysis.
Manoharan S; Ying LY
Int J Clin Pract; 2023; 2023():1068000. PubMed ID: 36793928
[TBL] [Abstract][Full Text] [Related]
9. Detrimental effects of COVID-19 in the brain and therapeutic options for long COVID: The role of Epstein-Barr virus and the gut-brain axis.
Hashimoto K
Mol Psychiatry; 2023 Dec; 28(12):4968-4976. PubMed ID: 37402856
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr Virus Lytic Replication Induces ACE2 Expression and Enhances SARS-CoV-2 Pseudotyped Virus Entry in Epithelial Cells.
Verma D; Church TM; Swaminathan S
J Virol; 2021 Jun; 95(13):e0019221. PubMed ID: 33853968
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 associated EBV reactivation and effects of ganciclovir treatment.
Meng M; Zhang S; Dong X; Sun W; Deng Y; Li W; Li R; Annane D; Wu Z; Chen D
Immun Inflamm Dis; 2022 Apr; 10(4):e597. PubMed ID: 35349757
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr Virus Coinfection in COVID-19.
Nadeem A; Suresh K; Awais H; Waseem S
J Investig Med High Impact Case Rep; 2021; 9():23247096211040626. PubMed ID: 34428954
[TBL] [Abstract][Full Text] [Related]
13. Inflammation and Epstein-Barr Virus at the Crossroads of Multiple Sclerosis and Post-Acute Sequelae of COVID-19 Infection.
Rousseau BA; Bhaduri-McIntosh S
Viruses; 2023 Apr; 15(4):. PubMed ID: 37112929
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus-acquired immunodeficiency in myalgic encephalomyelitis-Is it present in long COVID?
Ruiz-Pablos M; Paiva B; Zabaleta A
J Transl Med; 2023 Sep; 21(1):633. PubMed ID: 37718435
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr Virus Lytic Reactivation Induces IgG4 Production by Host B Lymphocytes in Graves' Disease Patients and Controls: A Subset of Graves' Disease Is an IgG4-Related Disease-Like Condition.
Nagata K; Hara S; Nakayama Y; Higaki K; Sugihara H; Kuwamoto S; Matsushita M; Kato M; Tanio S; Ishiguro K; Hayashi K
Viral Immunol; 2018 Oct; 31(8):540-547. PubMed ID: 30222515
[TBL] [Abstract][Full Text] [Related]
16. Human genetic and immunological determinants of SARS-CoV-2 and Epstein-Barr virus diseases in childhood: Insightful contrasts.
Pan-Hammarström Q; Casanova JL
J Intern Med; 2023 Aug; 294(2):127-144. PubMed ID: 36906905
[TBL] [Abstract][Full Text] [Related]
17. Discrepancy of Serological and Molecular Patterns of Circulating Epstein-Barr Virus Reactivation in Primary Sjögren's Syndrome.
Sanosyan A; Daien C; Nutz A; Bollore K; Bedin AS; Morel J; Zimmermann V; Nocturne G; Peries M; Guigue N; Gottenberg JE; Van de Perre P; Mariette X; Tuaillon E
Front Immunol; 2019; 10():1153. PubMed ID: 31191532
[TBL] [Abstract][Full Text] [Related]
18. Persistent SARS-CoV-2 Infection, EBV, HHV-6 and Other Factors May Contribute to Inflammation and Autoimmunity in Long COVID.
Vojdani A; Vojdani E; Saidara E; Maes M
Viruses; 2023 Jan; 15(2):. PubMed ID: 36851614
[TBL] [Abstract][Full Text] [Related]
19. Use of rituximab in SARS-CoV-2-positive renal transplant recipient with EBV reactivation and probable haemophagocytic lymphohistiocytosis.
Chan D; Karimi S; Follows G; Torpey N; Suchanek O
CEN Case Rep; 2023 Feb; 12(1):27-31. PubMed ID: 35729310
[TBL] [Abstract][Full Text] [Related]
20. Successful Treatment of SARS-CoV-2 Vaccination-related Activation of Rheumatoid Arthritis with Positive Findings for Epstein-Barr Virus.
Nakamura H; Nagasawa Y; Kobayashi H; Tsukamoto M; Takayama T; Kitamura N
Intern Med; 2022 Jul; 61(13):2073-2076. PubMed ID: 35466171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
